Phillips Barclay A Insider Trades

Insider Trading History

Track insider trading activity for Phillips Barclay A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Immunic
Immunic IMUX
Director
Holding Value $2.16M 150,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$116k 150,000 shares
$0.77
$14.43
Immunic
Immunic IMUX
Director
Holding Value $1.44M 100,000 shares
Last Trade
Jun 11, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$127k 100,000 shares
$1.27
$14.43
Immunic
Immunic IMUX
Director
Holding Value $0 0 shares
Last Trade
Mar 04, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$23k 15,000 shares
$1.53
$14.43
Immunic
Immunic IMUX
Director
Holding Value $0 0 shares
Last Trade
Mar 04, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$15.3k 9,986 shares
$1.53
$14.43
Immunic
Immunic IMUX
Director
Holding Value $0 0 shares
Last Trade
Mar 04, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$15.3k 10,000 shares
$1.53
$14.43
Immunic
Immunic IMUX
Director
Holding Value $937k 64,959 shares
Last Trade
Mar 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$99.4k 64,959 shares
$1.53
$14.43
Immunic
Immunic IMUX
Director
Holding Value $0 0 shares
Last Trade
Mar 04, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$15.3k 10,000 shares
$1.53
$14.43
Immunic
Immunic IMUX
Director
Holding Value $231k 16,000 shares
Last Trade
Jun 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31k 16,000 shares
$1.94
$14.43
Immunic
Immunic IMUX
Director
Holding Value $144k 10,000 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34k 10,000 shares
$3.40
$14.43
Immunic
Immunic IMUX
Director
Holding Value $144k 10,000 shares
Last Trade
Jun 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$148k 10,000 shares
$14.77
$14.43
Immunic
Immunic IMUX
Director
Holding Value $216k 15,000 shares
Last Trade
Jul 02, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$185k 15,000 shares
$12.30
$14.43
Immunic
Immunic IMUX
Director
Holding Value $432k 29,959 shares
Last Trade
Nov 18, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$229k 29,959 shares
$7.63
$14.43
G1 Therapeutics
G1 Therapeutics GTHX
SVP & Chief Financial Officer
Holding Value $430k 60,000 shares
Last Trade
Jan 02, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.17M 60,000 shares
$19.56
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
SVP & Chief Financial Officer
Holding Value $35.8k 5,000 shares
Last Trade
Nov 15, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$209k 5,000 shares
$41.81
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
SVP & Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Nov 15, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$200k 5,000 shares
$39.92
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
SVP & Chief Financial Officer
Holding Value $680k 95,000 shares
Last Trade
Nov 15, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$209k 5,000 shares
$41.81
$7.16
G1 Therapeutics
G1 Therapeutics GTHX
SVP & Chief Financial Officer
Holding Value $1.79M 250,000 shares
Last Trade
Dec 06, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.87M 250,000 shares
$19.46
$7.16
Novavax
Novavax NVAX
Svp, Chief Financial Officer
Holding Value $394k 38,669 shares
Last Trade
Jul 31, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$42.8k 2,057 shares
$20.80
$10.19
Novavax
Novavax NVAX
Svp, Chief Financial Officer
Holding Value $373k 36,612 shares
Last Trade
May 11, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$463k 25,000 shares
$18.51
$10.19
Novavax
Novavax NVAX
Svp, Chief Financial Officer
Holding Value $118k 11,612 shares
Last Trade
Jan 31, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$42.8k 1,633 shares
$26.20
$10.19

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up